Avanos Medical, Inc. financial data

Symbol
AVNS on NYSE
Location
5405 Windward Parkway, Suite 100 South, Alpharetta, GA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 248 % +12.4%
Quick Ratio 97.4 % +28.1%
Debt-to-equity 35.6 % -0.14%
Return On Equity -58.2 % -4657%
Return On Assets -42.9 % -4658%
Operating Margin -69 % -1503%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46.4M shares +1.01%
Common Stock, Shares, Outstanding 46.4M shares +1.01%
Entity Public Float 907M USD -23.9%
Common Stock, Value, Issued 500K USD 0%
Weighted Average Number of Shares Outstanding, Basic 46.4M shares +0.87%
Weighted Average Number of Shares Outstanding, Diluted 46.4M shares -0.43%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 700M USD +2.7%
Research and Development Expense 22.9M USD -16.1%
Operating Income (Loss) -483M USD -1541%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -488M USD -1969%
Income Tax Expense (Benefit) -19.3M USD -539%
Net Income (Loss) Attributable to Parent -469M USD -3087%
Earnings Per Share, Basic -10 USD/shares -3097%
Earnings Per Share, Diluted -10 USD/shares -3097%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 70.5M USD -20.8%
Inventory, Net 151M USD -6.98%
Assets, Current 351M USD -25.6%
Deferred Income Tax Assets, Net 25.3M USD +283%
Property, Plant and Equipment, Net 115M USD +5.39%
Operating Lease, Right-of-Use Asset 29.9M USD +12.8%
Intangible Assets, Net (Excluding Goodwill) 122M USD -44.6%
Goodwill 394M USD -50.4%
Other Assets, Noncurrent 29.3M USD +13.6%
Assets 1.07B USD -35.5%
Accounts Payable, Current 54.2M USD 0%
Accrued Liabilities, Current 74.8M USD -9.55%
Liabilities, Current 148M USD -30.5%
Deferred Income Tax Liabilities, Net 6.3M USD -73.6%
Operating Lease, Liability, Noncurrent 21.4M USD -19.2%
Other Liabilities, Noncurrent 20.7M USD +95.3%
Liabilities 290M USD -32.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -32.6M USD +11.7%
Retained Earnings (Accumulated Deficit) -779M USD -151%
Stockholders' Equity Attributable to Parent 778M USD -36.7%
Liabilities and Equity 1.07B USD -35.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 25.7M USD
Net Cash Provided by (Used in) Financing Activities -29.1M USD -4057%
Net Cash Provided by (Used in) Investing Activities -9.1M USD -355%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.7M USD +10.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 70.5M USD -20.8%
Deferred Tax Assets, Valuation Allowance 3.9M USD -9.3%
Deferred Tax Assets, Gross 59.2M USD +2.6%
Operating Lease, Liability 35.5M USD -13.6%
Depreciation 19M USD -7.77%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -465M USD -4037%
Lessee, Operating Lease, Liability, to be Paid 48.2M USD -9.4%
Property, Plant and Equipment, Gross 269M USD +9.2%
Operating Lease, Liability, Current 9.5M USD -30.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.4M USD -20.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.2M USD -17%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +22.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.9M USD -49.4%
Deferred Tax Assets, Operating Loss Carryforwards 8.4M USD -18.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.5M USD -43.5%
Additional Paid in Capital 1.69B USD +0.96%
Amortization of Intangible Assets 213M USD +767%
Depreciation, Depletion and Amortization 9.6M USD -15.8%
Deferred Tax Assets, Net of Valuation Allowance 55.3M USD +3.56%
Share-based Payment Arrangement, Expense 15.2M USD +8.57%
Interest Expense 14.6M USD +19.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%